How Does the FDA Evaluate Vaccines?

The world returning to “normal” after COVID-19 will depend, in large part, on mass vaccinations. Dr. Henry Miller explains the Food and Drug Administration’s (FDA) process for considering and approving vaccines for emergency use. Even after approval, the FDA regulates the labeling of the vaccine – who it is approved for and how it can be used. The Centers for Disease Control and Prevention (CDC) then makes recommendations to local entities about how to prioritize the population for vaccine distribution.

Dr. Henry Miller is a Senior Fellow at the Pacific Research Institute. He was the founding director of the Office of Biotechnology at the FDA.

Henry I. Miller

Senior Fellow

Pacific Research Institute

FDA & Health

The Federalist Society and Regulatory Transparency Project take no position on particular legal or public policy matters. All expressions of opinion are those of the speaker(s). To join the debate, please email us at [email protected].

Related Content

Skip to content